MariMed Balance Sheet Health
Financial Health criteria checks 1/6
MariMed has a total shareholder equity of $88.9M and total debt of $66.4M, which brings its debt-to-equity ratio to 74.7%. Its total assets and total liabilities are $196.1M and $107.2M respectively. MariMed's EBIT is $15.1M making its interest coverage ratio 1.7. It has cash and short-term investments of $14.7M.
Key information
74.7%
Debt to equity ratio
US$66.38m
Debt
Interest coverage ratio | 1.7x |
Cash | US$14.73m |
Equity | US$88.91m |
Total liabilities | US$107.21m |
Total assets | US$196.12m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MRMD's short term assets ($51.4M) exceed its short term liabilities ($30.9M).
Long Term Liabilities: MRMD's short term assets ($51.4M) do not cover its long term liabilities ($76.3M).
Debt to Equity History and Analysis
Debt Level: MRMD's net debt to equity ratio (58.1%) is considered high.
Reducing Debt: MRMD's debt to equity ratio has increased from 24.7% to 74.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if MRMD has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if MRMD has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.